Does red light therapy work?

Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.

1. 1

   Photobiomodulation: The Clinical Applications of Low-Level Light Therapy

   Aesthetic Surgery Journal (Glass)Published Jan 20, 2021Checked Sep 30, 2026

   “A reasonable body of clinical trial evidence exists to support the role of low-energy red/near-infrared light as a safe and effective method of skin rejuvenation, treatment of acne vulgaris and alopecia, and, especially, body contouring. Methodologic flaws, small patient cohorts, and industry funding mean there is ample scope to improve the quality of evidence. It remains unclear if light-emitting diode sources induce physiologic effects of compararable nature and magnitude to those of the laser-based systems used in most of the higher-quality studies. LLLT is here to stay. However, its ubiquity and commercial success have outpaced empirical approaches on which solid clinical evidence is established. Thus, the challenge is to prove its therapeutic utility in retrospect. Well-designed, adequately powered, independent clinical trials will help us answer some of the unresolved questions and enable the potential of this therapy to be realized.”

2. 2

   The effectiveness of low-level laser therapy for nonspecific chronic low back pain: a systematic review and meta-analysis

   Arthritis Research & Therapy (Huang et al.)Published Dec 1, 2015Checked Sep 30, 2026

   “Of 221 studies, seven RCTs (one triple-blind, four double-blind, one single-blind, one not mentioning blinding, totaling 394 patients) met the criteria for inclusion. Based on five studies, the WMD in visual analog scale (VAS) pain outcome score after treatment was significantly lower in the LLLT group compared with placebo (WMD = -13.57 [95 % CI = -17.42, -9.72], I(2) = 0 %). No significant treatment effect was identified for disability scores or spinal range of motion outcomes. Our findings indicate that LLLT is an effective method for relieving pain in NSCLBP patients. However, there is still a lack of evidence supporting its effect on function.”

3. 3

   Safety and Effectiveness of Low-Level Laser Therapy in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis

   Journal of lasers in medical sciences (Rayegani et al.)Published Aug 29, 2017Checked Sep 30, 2026

   “In order to gather evidence, main medical databases as well as relevant websites were browsed without time limit. We searched with appropriate keywords and strategies. After quality assessment of studies, study data were extracted by two reviewers. Standard mean difference proposed through Inverse Variance was used in the meta-analysis using the random-effects model. Twelve values were used for the evaluation of heterogeneity. A total of 823 studies, 14 RCTs were selected after final review. There was a significant difference between LLLT and Placebo in pain at rest (p=0.02), pain at activity (p=0.01), total pain (p=0.03), WOMAC function (p=0.01), WOMAC stiffness (p=0.02) and WOMAC total (p<0.0001) in favor of the LLLT. There was no significant difference between LLLT and Placebo in WOMAC pain (p=0.09) and range of motion (p=0.1). In spite of some positive findings, this meta-analysis lacked data on how LLLT effectiveness is affected with important factors: wavelength, energy density, treatment duration, numbers of sessions the treatment, severity of KOA and site of application.”

4. 4

   Safety of repeated low-level red-light therapy for myopia: A systematic review

   Asia-Pacific Journal of Ophthalmology (Chen et al.)Published Nov 1, 2024Checked Sep 30, 2026

   “Among 689 screened articles, 20 studies (2.90 %; median duration 9 months, longest 24 months) were analysed, encompassing 2380 participants aged 3-18 years and 1436 individuals undergoing RLRL therapy. Two case reports described an identical patient with reversible decline in visual acuity and optical coherence tomography (OCT) abnormalities, completely resolved 4 months after treatment cessation. No cases of permanent vision loss were reported. Temporary afterimage was the most common ocular symptom following treatment, resolving within 6 minutes in reported studies. The number needed to harm outweighed the number needed to treat by a ratio of 12.7-21.4 for a person with -3D to -8D myopia treated with RLRL therapy. Incidence of side effects from RLRL was 0.088 per 100 patient-years (95 % confidence interval, 0.02-0.50). No irreversible visual function loss or ocular structural damage was identified with RLRL. Fundus photography and OCT before and during therapy, alongside home monitoring of visual acuity and duration of afterimages, are necessary to identify side effects. Further adequately powered studies of longer duration are needed to evaluate long-term safety of RLRL.”

5. 5

   Photobiomodulation—Underlying Mechanism and Clinical Applications

   Journal of Clinical Medicine (Dompé et al.)Published Jun 3, 2020Checked Sep 30, 2026

   “The interest in the application of laser therapy in medicine and dentistry has remarkably increased in the last decade. There are different types of lasers available and their usage is well defined by different parameters, such as: wavelength, energy density, power output, and duration of radiation. Laser irradiation can induce a photobiomodulatory (PBM) effect on cells and tissues, contributing to a directed modulation of cell behaviors, enhancing the processes of tissue repair. Photobiomodulation (PBM), also known as low-level laser therapy (LLLT), can induce cell proliferation and enhance stem cell differentiation. Laser therapy is a non-invasive method that contributes to pain relief and reduces inflammation, parallel to the enhanced healing and tissue repair processes. The application of these properties was employed and observed in the treatment of various diseases and conditions, such as diabetes, brain injury, spinal cord damage, dermatological conditions, oral irritation, and in different areas of dentistry.”

6. 6

   The importance of power in photobiomodulation: a systematic review and meta-analysis of high-intensity laser therapy.

   Frontiers in integrative neuroscience (Penberthy & Vorwaller)Published Sep 14, 2026Checked Oct 4, 2026

   “HILT yielded durable analgesia, with large VAS pain reductions at end of treatment, k = 50, 19, and 21, respectively). Functional outcomes improved consistently, including range of motion (92%; k = 26), functional performance (84%; k = 57), and quality of life (85%; k = 25). Structural and physiological changes were observed, including increased knee cartilage thickness, reduced rotator cuff tear size, weight loss, and improved nerve conduction. Comparative trials showed HILT produced greater pain reduction than LLLT in 13/13 studies, all with large effect sizes. Mean HILT power was 9.3 W (median 10.0; range 0.5-30), and mean power density was 19.5 W/cm2 (median 10; range 0.1-52.5).ConclusionClass IV high-intensity laser therapy appears effective and safe for durable pain reduction across deep-tissue musculoskeletal pathologies, supporting its recognition in clinical practice and coverage by payers as a valuable therapeutic option. Further multicenter trials are needed to refine treatment protocols.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420251021772, identifier CRD420251021772.”

7. 7

   Laser auriculotherapy for the treatment of pain: a scoping review.

   Lasers in medical science (José et al.)Published Sep 14, 2026Checked Oct 4, 2026

   “The final search was conducted in May 2025.ResultsSeven studies were included. PBM in auriculotherapy demonstrated positive trends in pain reduction for chronic lower back pain and temporomandibular dysfunction. However, no significant differences were found in acute postoperative pain or knee osteoarthritis. Protocols utilized infrared (808-904 nm) or red (650-660 nm) wavelengths, with energy densities ranging from 0.54 to 4 J/cm². The most frequently stimulated points were Shen Men (85.7%), Sympathetic, Kidney, Liver, and Subcortex (42.8% each). Treatment regimens typically consisted of 8 to 10 sessions, performed once or twice weekly. Heterogeneity and incomplete reporting of dosimetry parameters were observed across the literature.ConclusionLaser auriculotherapy is a promising non-invasive approach for chronic musculoskeletal pain. However, substantial variability in parameters and methodological inconsistencies limit comparability. Standardized reporting and larger controlled trials are essential to define optimal protocols for auricular PBM.”

8. 8

   What to Look for in Red Light Therapy: A Product Guide Backed by Science.

   Cureus (Spongberg et al.)Published Mar 17, 2026Checked Oct 4, 2026

   “The downstream effects of mitochondrial efficiency improve wound healing, pain relief, and aesthetic outcomes. Although early research has encouraging results, the exact pathways by which PBM exerts its effects are still under investigation. PBM is known by other names, including red light therapy and low-level light therapy. Consumer devices are available in many forms, such as masks, wands, hand-held panels, laser caps, and full-body systems. With the rise in popularity, understanding the underlying biological mechanisms of PBM is becoming increasingly important. Equally critical is the selection of a product that has undergone the necessary U.S. Food and Drug Administration (FDA) channels, ensuring the device is backed by scientific evidence. This paper specifically serves as a guide for selecting safe, evidence-based PBM mask devices. This review discusses the mitochondrial and enzymatic mechanisms of action while providing a comprehensive literature review of available mask products that are both FDA-cleared and supported by scientific papers.”

9. 9

   Clinical dosimetry and efficacy of LED photobiomodulation for chronic lower-limb wound healing: a systematic review of randomized trials.

   Lasers in medical science (Miranda et al.)Published Jun 19, 2026Checked Oct 4, 2026

   “A comprehensive search was conducted in PubMed, Scopus, Web of Science, and Embase up to May 2026. Six randomized clinical trials met the inclusion criteria. Wavelengths ranged from 620 to 950 nm, and energy densities varied between 2.4 and 126 J/cm². The findings suggest that LED photobiomodulation may promote wound area reduction, improve wound bed quality, and increase microcirculation, particularly in diabetic foot ulcers. However, one study using a high energy density (126 J/cm²) did not demonstrate beneficial effects, suggesting a possible dose-dependent response. The overall certainty of the evidence, assessed using the GRADE approach, was classified as very low due to inconsistency and indirectness among the included studies. Although LED photobiomodulation appears to be safe and demonstrates therapeutic potential, substantial heterogeneity in irradiation parameters, small sample sizes, and methodological limitations preclude definitive conclusions regarding its clinical efficacy. Well-designed randomized controlled trials with standardized protocols and dose-response investigations are needed to establish optimal therapeutic parameters and confirm clinical efficacy.”